Emergent Biosolutions Inc. buy Benchmark Co.
Start price
11.04.24
/
50%
€2.04
Target price
11.04.25
€4.65
Performance (%)
464.95%
Price
23.07.24
€11.53
Summary
This prediction is currently active. The BUY prediction by Benchmark_Co_ for Emergent Biosolutions Inc. has seen massive gains of 464.95%. This prediction currently runs until 11.04.25. The prediction end date can be changed by Benchmark_Co_ at any time. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Emergent Biosolutions Inc. | 3.782% | 3.782% |
iShares Core DAX® | -0.116% | 1.953% |
iShares Nasdaq 100 | -2.733% | -1.273% |
iShares Nikkei 225® | -1.721% | 3.263% |
iShares S&P 500 | -1.527% | 0.194% |
Comments by Benchmark_Co_ for this prediction
In the thread Emergent Biosolutions Inc. diskutieren
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.
Ratings data for EBS provided by MarketBeat
Stopped prediction by Benchmark_Co_ for Emergent Biosolutions Inc.
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€7.40
02.07.24
02.07.24
€7.44
02.07.25
02.07.25
55.66%
23.07.24
23.07.24
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€6.00
20.06.24
20.06.24
€7.46
20.06.25
20.06.25
92.08%
23.07.24
23.07.24
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€2.53
07.03.24
07.03.24
€4.58
07.03.25
07.03.25
356.25%
23.07.24
23.07.24
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€11.36
10.04.23
10.04.23
€20.27
10.04.24
10.04.24
-82.04%
11.04.24
11.04.24